Krupa Jani, a devoted scientist and clinical laboratory technologist, occupies a prominent position in the realms of molecular biology and virology. Driven by a fervent curiosity for unraveling molecular mysteries, she has amassed a wealth of expertise and experience through her academic pursuits and professional endeavors. Her journey, characterized by academic distinction, pioneering research, and meaningful contributions, serves as a testament to her dedication to advancing scientific understanding and enhancing patient care.

Her academic voyage commenced at N.V. Patel College of Pure and Applied Sciences, Sardar Patel University, India, where she obtained a Bachelor’s degree in Genetics. Subsequently, she pursued a Master’s program in Forensic Science with a specialization in Biology and Biotechnology at the Institute of Forensic Science, Gujarat Forensic Sciences University, India. Her academic trajectory culminated at the esteemed John Jay College of Criminal Justice, City University of New York, where she earned a Master’s in Forensic Science, specializing in Molecular Biology.

Armed with a robust educational foundation, she embarked on a fulfilling professional journey. Presently serving as a Clinical Laboratory Technologist II at a premier cancer hospital in New York City, she has significantly contributed to the field of clinical microbiology. From validating diagnostic kits to troubleshooting procedures, Krupa has adeptly utilized state-of-the-art technologies, including Next-Generation Sequencing and quantitative PCR. Her proficiency extends to various DNA extraction and amplification techniques, alongside comprehensive data analysis for Next-Generation Sequencing data.

Before assuming her current role, she gained valuable experience as a Research Intern, evaluating genetic kits for phenotypic identification using Next Generation Sequencing platforms. Furthermore, her tenure as an Adjunct Lecturer at John Jay College underscored her commitment to disseminating knowledge and mentoring students.

Among her notable contributions is the automation of several infectious disease molecular tests, a testament to her innovation and dedication beyond conventional practices. Notably, her efforts in Next Generation Sequencing have been pivotal in studying SARS-CoV-2 variants and investigating long COVID and viral shedding in immunocompromised patients.

Her impact transcends the laboratory, evidenced by her extensive body of research publications and presentations. Her work, spanning diagnostic assay evaluations to SARS-CoV-2 variant analyses, has been featured in prestigious journals such as the Journal of Clinical Microbiology and Clinical Infectious Diseases. Additionally, her presentations at renowned conferences like ASM Microbe and AMP Annual Meeting have provided valuable insights into emerging infectious diseases and molecular diagnostics. She also actively contributes to international microbiology societies as a committee member, facilitating the dissemination of new technologies to fellow scientists.

Her contributions have garnered recognition through various awards, including the PASCV Travel Award for excellence in Molecular Virology and the Technologist Poster Award at the AMP Annual Meeting. These accolades underscore her unwavering commitment to scientific excellence and innovation.

In essence, Her journey epitomizes the convergence of academic rigor, professional prowess, and research excellence. As she continues to push the boundaries of scientific knowledge and innovation, her contributions are poised to leave a profound and enduring impact on the fields of molecular biology and forensic science. With a steadfast commitment to advancing healthcare and enhancing patient outcomes, she serves as an inspiration for aspiring scientists worldwide.